We determined the presence of FGFR2 amplification by using the qPCR-based gene copy number assay, and found that FGFR2 amplification was present in 4.9% of the patients with metastatic or locally advanced unresectable gastric cancer. The gene discussed is FGFR2; the disease is gastric cancer.